GSK
UK Parkinson’s Single-Cell Research Project Kicks off With £4M From Gatsby Charitable Foundation
The three-year public-private research partnership has also garnered financial support from pharmaceutical companies GSK, Novartis, Roche, and UCB.
Project Africa GRADIENT aims to gather and analyze pharmacogenetic data specific to African populations with funding from Novartis and GlaxoSmithKline.
Neoadjuvant Jemperli Continues to Show 100 Percent Complete Response Rate in dMMR Rectal Cancer
Premium
The immunotherapy led to durable responses, with 24 patients experiencing a complete response for at least one year.
GSK, Ivy Brain Tumor Center to Begin Phase III Trial of Zejula in MGMT Unmethylated Glioblastoma
The Phase III trial was initiated after researchers reported promising results from a Phase 0/II trial of Zejula in this setting.
BRCAaway Study Data Shed Light on Frontline mCRPC Strategies, but 'Debate Will Not End Today'
Premium
Updated trial data suggest benefit with a three-drug combo containing the PARP inhibitor Lynparza, but questions remain about comparative efficacy of sequential therapy.